Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 18 of 25

COMPLETED NA

The Effect of Resistance to Participant-Supported Reaching on Workspace of the Hand in Severe Chronic Stroke

NCT01548781

COMPLETED

Epidemiology of Osteoarthritis (OA) Pain

NCT01557231

COMPLETED NA

Improving Rates of Repeat Colorectal Cancer Screening

NCT01453894

TERMINATED NA

Reletex for Nausea in GERD Patients

NCT01582100

COMPLETED Phase 1

Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy

NCT01313117

COMPLETED

Excimer Laser Assisted IVC Filter Retrieval

NCT02240251

COMPLETED NA

Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness

NCT01529996

TERMINATED

Patient Positioning on Supraclavicular Nerve Block

NCT01615952

TERMINATED Phase 2

Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

NCT01478321

COMPLETED Phase 1

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

NCT01465659

COMPLETED

Home Sleep and Circadian Phase: Mediators of Diabetes Risk

NCT01786564

COMPLETED NA

Evaluation of the Effectiveness of Daily Pulse Lavage Therapy in Chronic Wounds

NCT01500746

TERMINATED NA

Intracutaneous Sterile Water Injections

NCT01513447

COMPLETED NA

A New Insertion Technique for Laryngeal Mask Airway

NCT01749033

COMPLETED Phase 2

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

NCT01476410

COMPLETED NA

Incidence of Headache Following an Unintentional Dural Puncture

NCT01977898

COMPLETED NA

Make Better Choices

NCT01249989

COMPLETED Phase 4

High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia

NCT01569659

TERMINATED Phase 4

Preemptive Analgesia Following Uterine Artery Embolization

NCT01555073

TERMINATED Phase 3

Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial

NCT01445821

COMPLETED NA

Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)

NCT01408901

COMPLETED NA

A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery

NCT01451762

COMPLETED NA

A Randomized Study to Abate Truancy and Violence in Grades 3-9 in Chicago Public Schools

NCT01487434

COMPLETED NA

A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination

NCT01432860

COMPLETED Phase 1

Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer

NCT01325207

COMPLETED NA

Ketamine Infusion and Hypoventilation

NCT01535976

COMPLETED

Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?

NCT01784341

COMPLETED NA

Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study

NCT01435603

TERMINATED NA

Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease

NCT01544465

TERMINATED NA

Glaucoma Eye Drop Instillation: Impact of Education

NCT01416415

TERMINATED

Effect of Vitamin D Supplementation on In-vitro Fertilization (IVF) Outcomes

NCT01419743

COMPLETED Phase 1

ENGAGED: E-Networks Guiding Adherence to Goals for Exercise and Diet

NCT01051713

COMPLETED NA

Brain Morphometry in OA Patients Treated With Duloxetine

NCT02903238

COMPLETED NA

Daily Checklists and Outcome in the Intensive Care Unit

NCT01396044

COMPLETED

Correlation of Donor-specific Anti-endothelial Cells

NCT01545713

COMPLETED Early Phase 1

Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine

NCT01380353

COMPLETED NA

PharmacoMRI of Parkinson Disease

NCT01528592

TERMINATED Phase 3

Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease

NCT01652534

COMPLETED NA

A Trial Comparing Combined Spinal- Epidural Dosing Strategies for External Cephalic Version

NCT01991743

COMPLETED Phase 1

Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

NCT01259089

COMPLETED

4R for Guideline Indicated BRCA Testing of Breast Center Patients

NCT01320540

COMPLETED NA

Treatment of Keratosis Pilaris With 810 nm Diode Laser

NCT01281644

TERMINATED Phase 2

Genistein in Treating Patients With Prostate Cancer

NCT01126879

COMPLETED NA

The Effect of Magnesium Sulfate Infusion on the Quality of Recovery of Ambulatory Patients

NCT01433081

COMPLETED NA

Comparing the Pain Experience Between Patients Who Have and Who Have Not Undergone Dermatologic Procedures

NCT01285947

COMPLETED NA

Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone

NCT01186835

TERMINATED

Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer

NCT01259076

COMPLETED Phase 4

Infrapatellar Nerve Block for Post-operative Knee Arthroscopy Pain Control

NCT01279447

COMPLETED NA

Tailored Communication to Reduce Cardiovascular Risk

NCT01286311

COMPLETED Phase 1

Reduction of IgE Antibody in Human Allergic Subjects

NCT01280149

← Previous Page 18 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.